141 results
Page 5 of 8
8-K
EX-99.2
6s08a83k axcsi9ao0
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-99.1
a5c50vfctt4kjymw
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-10.1
gt6z5n7ou0t8pjfl
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
8-K
EX-99.1
ie7oa2xgd0p
11 Feb 19
Company now focused on completing plan to resubmit NDA in first half of 2019
5:00pm
8-K
EX-1.1
q8pmd
23 Jan 19
Entry into a Material Definitive Agreement
8:04am
424B5
5ayoemdbslw6ro1n3bz
23 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-99.1
ek47zjvjt1lyncb8
10 Jan 19
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
4:20pm
8-K
loxizwu
10 Jan 19
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
4:20pm
8-K
EX-99.1
7i47 yt1pk93gt4b
7 Jan 19
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
2ovonr6x
1 Nov 18
Agile Therapeutics Reports Third Quarter 2018 Financial Results
4:31pm
8-K
EX-99.1
rud2xuyfvfa7s37pdi
24 Oct 18
Other Events
8:13am
8-K
8cvsq v0e
24 Oct 18
Other Events
8:13am
8-K
wjz m8awc
9 Oct 18
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
8:09am
8-K
EX-99.1
ik7h7sr 88
9 Oct 18
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
8:09am
8-K
EX-99.1
x6bx mnjehxz74
5 Oct 18
Other Events
12:00am
8-K
uezauh2z7l02xxv9pc
5 Oct 18
Other Events
12:00am